# Jade Biosciences, Inc.: Form 8-K, filed Oct 10, 2024

- Company: [Jade Biosciences, Inc.](/companies/jbio.md) (CIK 1798749)
- Form: 8-K
- Filed: 2024-10-10
- Accepted by EDGAR: Oct 10, 2024, 17:04 ET
- Period: 2024-10-06
- Accession: 0001798749-24-000052
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1798749/000179874924000052/tmb-20241006x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1798749/000179874924000052/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1798749/000179874924000052/tmb-20241006x8k.htm

Filed Oct 10, 2024.
Source: SEC EDGAR, the filing index for accession 0001798749-24-000052. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.